Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chang-An Jun-Tai Granule
- Development stage
- Preclinical
- Lead developer
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Administration
- Oral
01
Overview
**Chang-An Jun-Tai Granule** is an oral traditional Chinese medicine granular formulation being clinically evaluated in China for **irritable bowel syndrome with diarrhea**. A multicenter, randomized, placebo-controlled trial sponsored by The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine was registered as ChiCTR1900026373. The product is a traditional Chinese medicine formula; its individual constituents, defined molecular targets, and validated pharmacologic mechanism have not been publicly established in the identified registry record.
- Brand names
- Chang-An Jun-Tai Granule
- Other names
- Chang-An Jun-Tai GranuleChang-An-Jun-Tai Granules肠安菌泰颗粒
Beyond the preview
Go deeper on Chang-An Jun-Tai Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chang-An Jun-Tai Granule.